Have a question or want to speak with a team member?
Stay updated on our progress in changing the landscape of ovarian cancer treatment options and outcomes.
Jun 17, 2022
Prize awarded to researcher whose ovarian cancer vaccines are in preclinical studies funded by Ovarian Cancer Canada
Qingchuan Zhao’s research awarded the 2022 Anita Unruh Prize from Ovarian Cancer Canada
Dec 7, 2021
Ovarian Cancer Canada and the Cancer Research Society invest $2.25 million
Ovarian Cancer Canada and the Cancer Research Society invest $2.25 million in ovarian cancer research: Funding for 10 new projects just announced
Aug 17, 2021
Harnessing the power of vaccines to treat ovarian cancer
Most of us have recently heard a great deal about how vaccines help protect against the serious effects of COVID-19. But did you know that vaccines can also be used to treat disease?
Jun 15, 2021
Enabling research on rare forms of ovarian cancer
Dr. Mark Carey is developing scientific models to advance research on low-grade serous cancer, a rare form of the disease.
Apr 6, 2021
IRICoR and Ovarian Cancer Canada announce $2.3M
IRICoR and Ovarian Cancer Canada announce $2.3M for development of new treatments for ovarian cancer
Mar 30, 2021
$1.35 million for ovarian cancer research
The Cancer Research Society and Ovarian Cancer Canada are proud to jointly launch a competition to fund some of Canada’s most promising research projects focused on ovarian cancer. The competition will award up to 6 grants, each totaling $225,000 over a two-year period.
Feb 23, 2021
The benefits of 3D models in ovarian cancer research
These will enable scientists to test new treatments, leading to new clinical trials, and ultimately improved outcomes for women with this disease.
Nov 18, 2020
OvCAN Patient Partners inform research with their lived experience
OvCAN Patient Partners have important roles in a wide range of activities, from reviewing clinical trial funding applications to sharing their lived experience directly with ovarian cancer researchers and scientists.
Nov 2, 2020
Researchers examine new drug target with potential to improve treatment
Dr. Kirk McManus and Dr. Mark Nachtigal's collaborative research project was recently awarded two years’ joint funding from Ovarian Cancer Canada and the Cancer Research Society.